243 related articles for article (PubMed ID: 29623076)
1. Autoantibodies in Serum of Systemic Scleroderma Patients: Peptide-Based Epitope Mapping Indicates Increased Binding to Cytoplasmic Domains of CXCR3.
Recke A; Regensburger AK; Weigold F; Müller A; Heidecke H; Marschner G; Hammers CM; Ludwig RJ; Riemekasten G
Front Immunol; 2018; 9():428. PubMed ID: 29623076
[TBL] [Abstract][Full Text] [Related]
2. Antibodies against chemokine receptors CXCR3 and CXCR4 predict progressive deterioration of lung function in patients with systemic sclerosis.
Weigold F; Günther J; Pfeiffenberger M; Cabral-Marques O; Siegert E; Dragun D; Philippe A; Regensburger AK; Recke A; Yu X; Petersen F; Catar R; Biesen R; Hiepe F; Burmester GR; Heidecke H; Riemekasten G
Arthritis Res Ther; 2018 Mar; 20(1):52. PubMed ID: 29566745
[TBL] [Abstract][Full Text] [Related]
3. Anti-Ephrin Type-B Receptor 2 (EphB2) and Anti-Three Prime Histone mRNA EXonuclease 1 (THEX1) Autoantibodies in Scleroderma and Lupus.
Azzouz DF; Martin GV; Arnoux F; Balandraud N; Martin T; Dubucquoi S; Hachulla E; Farge-Bancel D; Tiev K; Cabane J; Bardin N; Chiche L; Martin M; Caillet EC; Kanaan SB; Harlé JR; Granel B; Diot E; Roudier J; Auger I; Lambert NC
PLoS One; 2016; 11(9):e0160283. PubMed ID: 27617966
[TBL] [Abstract][Full Text] [Related]
4. Epitope Specificity Determines Pathogenicity and Detectability of Anti-Platelet-Derived Growth Factor Receptor α Autoantibodies in Systemic Sclerosis.
Moroncini G; Grieco A; Nacci G; Paolini C; Tonnini C; Pozniak KN; Cuccioloni M; Mozzicafreddo M; Svegliati S; Angeletti M; Kazlauskas A; Avvedimento EV; Funaro A; Gabrielli A
Arthritis Rheumatol; 2015 Jul; 67(7):1891-903. PubMed ID: 25808833
[TBL] [Abstract][Full Text] [Related]
5. Computational analysis of high-density peptide microarray data with application from systemic sclerosis to multiple sclerosis.
Hecker M; Lorenz P; Steinbeck F; Hong L; Riemekasten G; Li Y; Zettl UK; Thiesen HJ
Autoimmun Rev; 2012 Jan; 11(3):180-90. PubMed ID: 21621003
[TBL] [Abstract][Full Text] [Related]
6. Identification of an immunodominant epitope on RNA polymerase III recognized by systemic sclerosis sera: application to enzyme-linked immunosorbent assay.
Kuwana M; Kimura K; Kawakami Y
Arthritis Rheum; 2002 Oct; 46(10):2742-7. PubMed ID: 12384934
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies to a novel Rpp38 (Th/To) derived B-cell epitope are specific for systemic sclerosis and associate with a distinct clinical phenotype.
Koenig M; Bentow C; Satoh M; Fritzler MJ; Senécal JL; Mahler M
Rheumatology (Oxford); 2019 Oct; 58(10):1784-1793. PubMed ID: 31323671
[TBL] [Abstract][Full Text] [Related]
8. Anti-Ro60 Seropositivity Determines Anti-Ro52 Epitope Mapping in Patients With Systemic Sclerosis.
Gkoutzourelas A; Liaskos C; Mytilinaiou MG; Simopoulou T; Katsiari C; Tsirogianni A; Daoussis D; Scheper T; Meyer W; Bogdanos DP; Sakkas LI
Front Immunol; 2018; 9():2835. PubMed ID: 30581434
[TBL] [Abstract][Full Text] [Related]
9. B-Cell epitope mapping of DNA topoisomerase I defines epitopes strongly associated with pulmonary fibrosis in systemic sclerosis.
Rizou C; Ioannidis JP; Panou-Pomonis E; Sakarellos-Daitsiotis M; Sakarellos C; Moutsopoulos HM; Vlachoyiannopoulos PG
Am J Respir Cell Mol Biol; 2000 Mar; 22(3):344-51. PubMed ID: 10696071
[TBL] [Abstract][Full Text] [Related]
10. Mapping of B cell epitopes on desmoglein 3 in pemphigus vulgaris patients by the use of overlapping peptides.
Dworschak J; Recke A; Freitag M; Ludwig RJ; Langenhan J; Kreuzer OJ; Zillikens D; Schmidt E
J Dermatol Sci; 2012 Feb; 65(2):102-9. PubMed ID: 22261006
[TBL] [Abstract][Full Text] [Related]
11. Characteristic epitope recognition pattern of autoantibodies against eukaryotic ribosomal protein L7 in systemic autoimmune diseases.
Neu E; Hemmerich PH; Peter HH; Krawinkel U; von Mikecz AH
Arthritis Rheum; 1997 Apr; 40(4):661-71. PubMed ID: 9125248
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies to fibrillin 1 in systemic sclerosis: ethnic differences in antigen recognition and lack of correlation with specific clinical features or HLA alleles.
Tan FK; Arnett FC; Reveille JD; Ahn C; Antohi S; Sasaki T; Nishioka K; Bona CA
Arthritis Rheum; 2000 Nov; 43(11):2464-71. PubMed ID: 11083269
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies against the chemokine receptor 3 predict cardiovascular risk.
Müller FS; Aherrahrou Z; Grasshoff H; Heidorn MW; Humrich JY; Johanson L; Aherrahrou R; Reinberger T; Schulz A; Ten Cate V; Robles AP; Koeck T; Rapp S; Lange T; Brachaczek L; Luebber F; Erdmann J; Heidecke H; Schulze-Forster K; Dechend R; Lackner KJ; Pfeiffer N; Ghaemi Kerahrodi J; Tüscher O; Schwarting A; Strauch K; Münzel T; Prochaska JH; Riemekasten G; Wild PS
Eur Heart J; 2023 Dec; 44(47):4935-4949. PubMed ID: 37941454
[TBL] [Abstract][Full Text] [Related]
14. Unique epitopes for carbonic anhydrase II autoantibodies related to autoimmune retinopathy and cancer-associated retinopathy.
Adamus G; Yang S; Weleber RG
Exp Eye Res; 2016 Jun; 147():161-168. PubMed ID: 27185162
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies against C5aR1, C3aR1, CXCR3, and CXCR4 are decreased in primary Sjogren's syndrome.
Yue X; Deng F; Chen J; Yin J; Zheng J; Chen Y; Huang Q; Gao X; Liu Z; Luo J; Müller A; Heidecke H; Riemekasten G; Petersen F; Yu X
Mol Immunol; 2021 Mar; 131():112-120. PubMed ID: 33446393
[TBL] [Abstract][Full Text] [Related]
16. Functionally Active Antibodies to the Angiotensin II Type 1-Receptor Measured by a Luminometric Bioassay Do Not Correlate With Clinical Manifestations in Systemic Sclerosis: A Comparison With Antibodies to Vascular Receptors and Topoisomerase I Detected by ELISA.
Bankamp L; Preuß B; Pecher AC; Beucke N; Henes J; Klein R
Front Immunol; 2021; 12():786039. PubMed ID: 34956217
[TBL] [Abstract][Full Text] [Related]
17. Molecular recognition patterns of anti-topoisomerase I-antibodies in patients with systemic sclerosis before and after autologous stem cell transplantation.
Glaeser L; Henes J; Kötter I; Vogel W; Kanz L; Klein R
Clin Exp Rheumatol; 2018; 36 Suppl 113(4):28-35. PubMed ID: 29465357
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin receptor type 1 and endothelin receptor type A on immune cells mediate migration and the expression of IL-8 and CCL18 when stimulated by autoantibodies from systemic sclerosis patients.
Günther J; Kill A; Becker MO; Heidecke H; Rademacher J; Siegert E; Radić M; Burmester GR; Dragun D; Riemekasten G
Arthritis Res Ther; 2014 Mar; 16(2):R65. PubMed ID: 24612997
[TBL] [Abstract][Full Text] [Related]
19. Naturally occurring and disease-associated auto-antibodies against topoisomerase I: a fine epitope mapping study in systemic sclerosis and systemic lupus erythematosus.
Simon D; Czömpöly T; Berki T; Minier T; Peti A; Tóth E; Czirják L; Németh P
Int Immunol; 2009 Apr; 21(4):415-22. PubMed ID: 19211583
[TBL] [Abstract][Full Text] [Related]
20. Characterization of binding and quantification of human autoantibodies to PDGFRα using a biosensor-based approach.
Moroncini G; Cuccioloni M; Mozzicafreddo M; Pozniak KN; Grieco A; Paolini C; Tonnini C; Spadoni T; Svegliati S; Funaro A; Angeletti M; Gabrielli A
Anal Biochem; 2017 Jul; 528():26-33. PubMed ID: 28450104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
